echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > All cells matter: a roadmap for lymphoma stromal characterization

    All cells matter: a roadmap for lymphoma stromal characterization

    • Last Update: 2022-05-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Lymphoma is a blood cancer that usually starts in the lymph nodes


    In a March 2022 paper in Nature Cell Biology, researchers from the University of Tsukuba collected more than 100,000 NHCs, including follicular lymphocytes, from 27 human samples different types of lymphomas


    "Once the map was developed, we performed an analysis of gene expression differences between subgroups of lymph nodes affected by lymphoma of different types


    Another important finding of this study showed that human lymph nodes have distinct subsets of NHC that were not previously found in mouse lymph nodes


    Prof.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.